VT ablation in a patient with metallic AVR-MVR
Our route to LV is passing through IVS with a left bundle pacing system
A gate is opened in a new way
We published our technique with a sample case
@Dr_Santangeli@rodericktung#EPeeps#VT
https://t.co/4f751FtGti
Excited to have Brigham EP fellow Mohamed Gabr, MD presenting at #HRS2025!
He’ll share a novel approach to phrenic nerve displacement during VT ablation and explore how lesion size affects long-term outcomes in AF ablation 📏🫀
Catch both posters next Friday in Sessions I & III.
Dose-Dependent Ventricular Lesion Formation Using a Novel Large-Area Pulsed Field Ablation Catheter: A Preclinical Feasibility Study #OpenAccess@TomKueffer@TobiasReichlin@inselgruppe
https://t.co/8QNe78ZKyJ
A challenging case of interrupted IVC and a gigantic CS due to PLSVC triggering AF, with RF ablation limited by phrenic nerve proximity. Explore our innovative solution: PFA using a pentaspline catheter delivered via a superior right internal jugular approach @JorgeERomeroMD@MGabrMD@True_EP@utedrow
https://t.co/xJQ1CWtFBQ
We have 60 EP Fellows and Arrhythmia Scholars enjoying in person high level EP education and 1,456 watching online around the world for the 2024 EP Fellows Summit. #EPFS.
Elimination of Epicardial Scar-Related Ventricular Tachycardia With Endocardial Pulsed Field Ablation: First Clinical Report @CleClinicHVTI@omwazni@SroubekJ https://t.co/dcaUtRmwLJ
Q: What is the combined effect of early rhythm control + healthy lifestyles on the risk of ischemic stroke in patients w/ #AFib?
A: Early rhythm control + healthy lifestyle were associated w/ a significantly lower risk of ischemic #stroke. https://t.co/p3o4PmuZeI
Hybrid VT ablation combining video-assisted thoracoscopy with subxyphoid EA can be performed in the EP lab and provides improved access to the target area with better catheter maneuverability for mapping and ablation. @utedrow@True_EP@andres_miranda4
https://t.co/3kOeurPQg8
Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk @alvindasMD@guroledip
https://t.co/TWCVWx4AWn
It may be time to challenge the sequelae of the CAST trial for the right patients.
Safety and efficacy of long-term Sodium Channel Blocker therapy for Early Rhythm Control: The EAST-AFNET 4 trial https://t.co/8l0TRzjl0v
New publication alert 🚨 New data from #RealAF now out in @hrs_journal demonstrate effectiveness of RF catheter ablation for AF. Read about contemporary trends across 42 hospitals here: https://t.co/DXTSjfTZHD
@josoriomd@andres_miranda4 @BiosenseWebster @paulzei@JorgeERomeroMD
JACC: Clinical Electrophysiology Editor-in-Chief Dr. @shivkumarmd highlights our #HRS2024 event page featuring #JACC and #JACCCEP simultaneous publications and interviews with authors conducted by our editorial team.
Check it out here: https://t.co/f6qnSEsDMc
@ECAScardio 📜 Does asymptomatic atrial fibrillation exist?
👓 This review details the negative health consequences that may be a/w #AF, even if pts do not have sx, and speaks to alternate endpoints for AF management
✒️ @DrBradleyKnight and Dr. Carniero
🔗 https://t.co/UVXtPV7cHO